An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism

Overview

The purpose of this study is to assess the efficacy of a parent training program in the treatment of social and communication deficits in children with autism. Specifically, this study will evaluate a developmentally based parent delivered intervention in the community developed by Pacific Autism Center for Education (PACE).

Study Type

  • Study Type: Interventional
  • Study Design
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 2014

Detailed Description

There are many treatments that claim to be effective for children with autism; however many of these treatments have not been investigated using scientifically rigorous methodology. A variety of developmentally based parent delivered interventions are gaining popularity as a type of treatment parents utilize to improve symptoms related to their child's diagnosis of autism. Pacific Autism Center for Education (PACE)is a agency that provides a developmentally based parent delivered intervention in the community. Currently, this parent training program has not been evaluated using scientific methodology. Investigation into this community delivered treatment and its effectiveness to improve social and communication deficits will aid clinicians in providing better care for children with autism.

Interventions

  • Behavioral: Pacific Autism Center for Education (PACE ) developmentally based parent delivered intervention
    • Pacific Autism Center for Education (PACE ) developmentally based parent delivered intervention

Arms, Groups and Cohorts

  • Experimental: Pacific Autism Center for Education (PACE)
    • Behavioral: Pacific Autism Center for Education (PACE) developmentally based parent delivered intervention

Clinical Trial Outcome Measures

Primary Measures

  • Social Responsiveness Scale
    • Time Frame: Baseline and Week 12
    • Outcome measure is the change from week 12 relative to baseline.

Secondary Measures

  • Repetitive Behavior Scale
    • Time Frame: Baseline and Week 12
    • Outcome measure is the change from week 12 relative to baseline.
  • Family Empowerment Scale
    • Time Frame: Baseline and Week 12
    • Outcome measure is the change from week 12 relative to baseline.
  • Caregiver Strain questionnaire
    • Time Frame: Baseline and Week 12
    • Outcome measure is the change from week 12 relative to baseline.
  • Pediatric Quality of Life Inventory
    • Time Frame: Baseline and Week 12
    • Outcome measure is the change from week 12 relative to baseline.
  • Sensory Profile Questionnaire
    • Time Frame: Baseline and Week 12
    • Outcome measure is the change from week 12 relative to baseline.

Participating in This Clinical Trial

Inclusion Criteria

  • meets DSM-IV-TR criteria for an autism spectrum disorder (pervasive developmental disorder) on the basis of clinical evaluation and the research diagnostic methods
  • age range between 18 months and 6.11 years
  • male or female in good medical health
  • will be starting PACE parent training program
  • intends on continuing PACE program for a minimum of 12 weeks

Exclusion Criteria

  • medically unstable (e.g., more than one seizure a month)
  • a medical diagnosis that causes autism like symptomology (e.g., Fragile X, Down syndrome, Angelman's syndrome, tuberous sclerosis, Rett's disorder)

Gender Eligibility: All

Minimum Age: 18 Months

Maximum Age: 6 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Stanford University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Antonio Hardan, Associate Professor – Stanford University
  • Overall Official(s)
    • Antonio Y. Hardan, MD, Principal Investigator, Stanford University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.